Jones Financial Companies
IOVA icon

Jones Financial Companies’s Iovance Biotherapeutics IOVA Stock Holding History

Jones Financial Companies’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$41K Buy
11,686
+1,345
+13% +$4.3K ﹤0.01% 3016
2025
Q4 		$28.2K Buy
10,341
+5,100
+97% +$11.8K ﹤0.01% 2793
2025
Q3 		$11.1K Buy
5,241
+2,390
+84% +$5.64K ﹤0.01% 3041
2025
Q2 		$4.82K Buy
2,851
+375
+15% +$933 ﹤0.01% 3143
2025
Q1 		$8.81K Buy
2,476
+905
+58% +$4.67K ﹤0.01% 2763
2024
Q4 		$11.6K Buy
1,571
+310
+25% +$2.87K ﹤0.01% 2467
2024
Q3 		$12.1K Buy
1,261
+1,080
+597% +$10.2K ﹤0.01% 2153
2024
Q2 		$1.45K Buy
+181
New +$1.94K ﹤0.01% 2221

Other funds holding IOVA

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
MFM
MHR Fund Management New York $1.37B AUM 68.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.17B AUM 0.03% 1-Year Est. Return